SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-22-016395
Filing Date
2022-04-28
Accepted
2022-04-28 15:35:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A eypt-defa14a_20220623.htm DEFA14A 23909
2 GRAPHIC gcs21dt1tunz000001.jpg GRAPHIC 82937
3 GRAPHIC gcs21dt1tunz000002.jpg GRAPHIC 61769
  Complete submission text file 0001564590-22-016395.txt   224687
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51122 | Film No.: 22866019
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services